Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Elisa Del Favero"'
Publikováno v:
Heliyon, Vol 9, Iss 5, Pp e15785- (2023)
Externí odkaz:
https://doaj.org/article/beeb504f230948579da3bcbd7aa54ee9
Autor:
Claudio Brasso, Marta Cisotto, Elisa Del Favero, Benedetta Giordano, Vincenzo Villari, Paola Rocca
Publikováno v:
Frontiers in Psychology, Vol 14 (2023)
IntroductionThe spread of the coronavirus disease 2019 (COVID-19) pandemic and the subsequent restrictions significantly affected mental health, especially major depressive disorder (MDD) whose incidence increased by 27.6% in 2020, after the COVID-19
Externí odkaz:
https://doaj.org/article/3ceba28bd0dc4d11a3bfe0da06d27533
Autor:
Paola Rocca, Paola Rucci, Cristiana Montemagni, Alessandro Rossi, Alessandro Bertolino, Eugenio Aguglia, Carlo A. Altamura, Mario Amore, Ileana Andriola, Antonello Bellomo, Claudio Brasso, Bernardo Carpiniello, Elisa Del Favero, Liliana Dell’Osso, Fabio Di Fabio, Michele Fabrazzo, Andrea Fagiolini, Giulia Maria Giordano, Carlo Marchesi, Giovanni Martinotti, Palmiero Monteleone, Maurizio Pompili, Rita Roncone, Rodolfo Rossi, Alberto Siracusano, Elena Tenconi, Antonio Vita, Patrizia Zeppegno, Silvana Galderisi, Mario Maj
Publikováno v:
European Psychiatry, Vol 66 (2023)
Abstract Background Deficits in social cognition (SC) are significantly related to community functioning in schizophrenia (SZ). Few studies investigated longitudinal changes in SC and its impact on recovery. In the present study, we aimed: (a) to es
Externí odkaz:
https://doaj.org/article/d728093353024086b52bda19a414ef9f
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 12 (2022)
Background: Partial adherence to antipsychotics is the most common cause of relapses and rehospitalization in patients with schizophrenia (SZ), leading to higher health care costs and psychosocial disability. The use of long-acting injectable (LAI) a
Externí odkaz:
https://doaj.org/article/820c3abf3a6240879bcde6d4f5b1bbea
Autor:
Cristiana Montemagni, Elisa Del Favero, Cecilia Riccardi, Laura Canta, Mario Toye, Enrico Zanalda, Paola Rocca
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
We aimed to evaluate in a sample of outpatients with schizophrenia (SCZ) the effectiveness of a cognitive remediation (CR) program (through the use of the Cogpack software) [computer-assisted CR (CACR)] in addition to standard therapy on cognitive ou
Externí odkaz:
https://doaj.org/article/85d08d9addd644f28cd88a5efefeca2c
Autor:
Elisa Del Favero, Cristiana Montemagni, Paola Bozzatello, Claudio Brasso, Cecilia Riccardi, Paola Rocca
Publikováno v:
Medicina, Vol 57, Iss 6, p 545 (2021)
The onset of prodromal symptoms in subjects who are at familial or clinical risk for bipolar disorder could be considered as an important alarm bell for the development of the disease and should be carefully detected. The management of prodromes in b
Externí odkaz:
https://doaj.org/article/827931cd655344fe9389d1bd74ab0b56
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elisa Del Favero, Laura Canta, Cristiana Montemagni, Mario Toye, Paola Rocca, E. Zanalda, Cecilia Riccardi
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Frontiers in Psychiatry
Frontiers in Psychiatry
We aimed to evaluate in a sample of outpatients with schizophrenia (SCZ) the effectiveness of a cognitive remediation (CR) program (through the use of the Cogpack software) [computer-assisted CR (CACR)] in addition to standard therapy on cognitive ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b81a0acd7b03c1d159416292e09999
https://www.frontiersin.org/articles/10.3389/fpsyt.2021.649737/full
https://www.frontiersin.org/articles/10.3389/fpsyt.2021.649737/full
Autor:
Claudio Brasso, Cristiana Montemagni, Elisa Del Favero, Silvio Bellino, Cecilia Riccardi, Paola Rocca
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 7457, p 7457 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 7457, p 7457 (2021)
Cognitive impairment is currently considered a core feature of schizophrenia (SZ) and is gaining attention as a fundamental therapeutic target. Standard treatment for SZ involves the use of antipsychotics that are successfully used to control positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9c24d08ac5c6957f798c39534716d7
http://europepmc.org/articles/PMC8307511
http://europepmc.org/articles/PMC8307511